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Background: Few studies have designed and tested the use of continuous quality improvement approaches in
community based substance use treatment settings. Little is known about the feasibility, costs, efficacy, and
sustainment of such approaches in these settings.
Methods/Design: A group-randomized trial using a modified stepped wedge design is being used. In the first
phase of the study, eight programs, stratified by modality (residential, outpatient) are being randomly assigned to
the intervention or control condition. In the second phase, the initially assigned control programs are receiving the
intervention to gain additional information about feasibility while sustainment is being studied among the pro-
grams initially assigned to the intervention.
Discussion: By using this design in a pilot study, we help inform the field about the feasibility, costs, efficacy and
sustainment of the intervention. Determining information at the pilot stage about costs and sustainment provides
value for designing future studies and implementation strategies with the goal to reduce the time between
intervention development and translation to real world practice settings.
Keywords: Continuous quality improvement, Group randomized controlled pilot trial, Stepped wedge design,
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Substance use is a significant public health problem,
with an estimated 8.9% of the U.S. population needing
treatment [1] and numerous social and financial costs
[2], yet improvement in the quality of care for substance
use disorders (SUDs) lags behind that of general health
care [3]. In 2006, the Institute of Medicine (IOM) rec-
ommended a multi-faceted strategy for improving SUD
care which included support for instituting quality im-
provement practices and increasing the use of evidence-
based practices in SUD treatment centers [3]. However,
to date the literature on effective implementation of
quality improvement practices in SUD treatment centers* Correspondence: shunter@rand.org
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stated.remains small [4-8]. Moreover, there is limited informa-
tion about CQI costs and sustainment [9-11] in these
settings.Continuous Quality Improvement (CQI)
One potentially promising method for improving
evidence-based practice delivery and quality of SUD
treatment services is Continuous Quality Improvement
(CQI), “a planned approach to transform organizations by
evaluating and improving systems to achieve better out-
comes” [12]. CQI is a concept that initially took root in
the U.S. manufacturing industry in the 1920’s to improve
quality and productivity [12]; now the same methods are
being used to improve the quality of health care [13]. CQI
involves the systematic assessment of program implemen-
tation and short-term outcomes in order to improve ser-
vice delivery and long-term outcomes. CQI differs fromLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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Hunter et al. Addiction Science & Clinical Practice 2014, 9:4 Page 2 of 11
http://www.ascpjournal.org/content/9/1/4traditional program evaluation approaches in that it in-
volves an iterative cycle of monitoring performance,
identifying problems and potential solutions, and imple-
menting changes, as well as the involvement of frontline
and other staff in the improvement process. Several
studies have successfully applied CQI to the health care
domain and provide evidence that CQI can be used to
improve patient outcomes [14-17]; a small but growing
literature suggests that CQI is feasible in SUD treatment
settings [4-6,8].
Available research suggests that CQI can be success-
fully used to address short-term process improvements
in SUD treatment settings, such as reducing wait times,
increasing admissions, enhancing retention, and decreas-
ing no-shows [4,10,18]. However, prior research is lim-
ited in scope in that it has focused primarily on process
improvements rather than organizational and client out-
comes, and it has yet to demonstrate evidence of long-
term sustainment past the implementation during the
research trial [9,11]. By sustainment, we refer to the con-
tinued use of CQI past implementation during the re-
search trial [19]. In contrast, sustainability refers to a
characteristic of an intervention that supports its contin-
ued use in practice [20]. Further, previous approaches
have used a top-down approach, required extensive data
tracking, and specifically focused on applying and meas-
uring the impact of pre-specified process improvements
selected by researchers [9,18,21]. In contrast, borrowing
from traditional quality approaches that engage multiple
levels within an organization to plan the process im-
provement [22], the CQI approach utilized in this study
has not been well studied in addiction treatment set-
tings. More specifically, a key difference between the
CQI approach utilized in this study and previous QI ini-
tiatives tested in addiction settings [21,23] is that this
CQI approach relies on treatment staff to determine the
area for improvement rather than pre-determined process
changes (e.g., reducing waiting time).
Organizational change and adoption of new practices
Certain key factors contribute to the adoption and sus-
tainment of new practices within organizational settings.
These include support and leadership commitment [24];
the input of local stakeholders in the selection of or-
ganizational priorities for change [25-27]; resources, in-
cluding money, materials, and access to expertise [26]; and
ongoing supervision or technical assistance [23,28-30]. To
facilitate adoption of new practices with organizations, in-
terventions should be perceived as compatible with existing
work practices, advantageous over similar practices, rela-
tively easy to use, and to have demonstrable results [31].
Adoption can be further enhanced through communication
networks and partnerships and through opinion leaders
[32]. Strategies to enhance adoption, implementation andsustainment of new practices include increasing self-
efficacy, confidence, and expectancies among staff about
implementation through tools such as training and model-
ing and through provision of technical assistance and re-
sources [32]. Organizational climate, such as staff cohesion,
presence of opinion leaders, and openness to change con-
tribute to an organization’s readiness to change, and thus
also contribute to the adoption and sustainment of new in-
terventions [31,33].
The present study
In light of the utilization lag of CQI in SUD treatment
settings, the paucity of effectiveness, sustainment, and
cost information, and the lack of CQI interventions de-
signed to specifically meet the needs of SUD treatment
settings, the present study is examining the feasibility,
preliminary efficacy, costs, and sustainment of imple-
menting a newly designed collaborative, participatory
CQI intervention [8,34]. The intervention includes a
CQI toolkit, training, and ongoing onsite technical as-
sistance. The CQI application uses data already being
collected within an organization to help staff identify
relevant areas for improvement; solicits input and guid-
ance from program leadership; and provides ongoing ac-
cess to a CQI expert for technical assistance. Further,
the study’s modified stepped wedge design allows for the
assessment of feasibility and sustainment during the
pilot phase, thus maximizing resources and streamlining
the movement of the intervention from research to prac-
tice. In a traditional stepped-wedge design, the trial is
staged over several time periods [35-37]; in the present
study, we have two study phases. A stepped wedge de-
sign typically is used when it is believed that the inter-
vention will do more good than harm [38] and/or when
there are practical or financial constraints to conducting
the intervention all at once [35]. In the present study,
we instituted this design to maximize the information
learned from the project. During the first phase, we col-
lect information on both feasibility (among the group
assigned to receive the intervention) and on efficacy, by
comparing outcomes between programs assigned to CQI
(Cohort 1) and the control (Cohort 2) sites. In the sec-
ond phase of the study, we continue to collect informa-
tion about intervention feasibility by assigning the
Cohort 2 sites to receive the CQI intervention while also
monitoring CQI sustainment among Cohort 1 sites. This
article describes the unique design, intervention proto-
col, and evaluation approach of this study.
Methods/Design
Study site and participants
The study site is a non-profit SUD treatment provider in
Los Angeles County that receives a mix of public and
private funding. Nonprofit providers represent the largest
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(as compared to for-profit [27%] and public [12%] pro-
grams) [39]. Consistent with recommendations for a col-
laborative approach to organizational change and to
CQI, the Director of Quality Assurance of the provider
organization is a co-Principal Investigator on the study.
We selected eight of the organization’s SUD treatment
programs to participate in the study. The eight programs
represent typical publicly funded addiction treatment
programs in Los Angeles County. We included four resi-
dential and four outpatient programs that are relatively
close in size and budget. The programs each serve on
average 197 (residential) or 320 (outpatient) diverse cli-
ents (i.e., 60% male; 26% White, 29% African American,
40% Hispanic, and 5% Asian and/or other) annually.
Average length of stay ranges from 85 to 115 days in
residential and outpatient treatment, respectively.
Although assignment to the CQI intervention is at the
program level, participants at multiple levels participate
in intervention activities. Specifically, onsite meetings
with clinical and administrative staff at each of the par-
ticipating programs are planned after random assign-
ment so that all clinical and administrative staff are
directly informed about the project. In addition, one
supervisor and one member from the clinical team from
each program assigned to the intervention are asked to
attend monthly CQI meetings held at the organization’s
headquarters with the other assigned program staff. The
staff that attend these monthly CQI meetings are re-
sponsible for bringing information back to their respect-
ive programs. Other clinical and administrative staff at
the sites are involved in the evaluation component of the
study.
Study design
The study is a group-randomized trial (GRT). Eight pro-
grams, stratified by modality (residential or outpatient),
are being randomly assigned to receive the intervention
either during the first study phase (these programs com-
prise ‘Cohort 1’) or the second (Cohort 2) (see Figure 1).
Study aims and hypotheses
The specific aims of this study are to 1) conduct a ran-
domized pilot study to assess the extent to which the
CQI intervention leads to process and outcome improve-
ments in the organization, and 2) investigate implementa-
tion feasibility across the organization, including the a)
processes and extent of implementation among staff, b)
cost of conducting CQI, and c) sustainment of the CQI
process within the programs over time. We hypothesize
that clients attending the intervention programs will stay
in treatment longer, achieve higher levels of treatment sat-
isfaction, have higher rates of positive treatment compli-
ance, and achieve higher functioning compared to clientsattending control programs. We expect that staff in pro-
grams participating in the CQI intervention will demon-
strate improvements in job morale, job satisfaction, and
attitudes towards evidence-based practices compared with
staff assigned to programs in the control condition. We
also hypothesize that intervention programs would experi-
ence lower staff attrition than programs assigned to the
control condition. These hypotheses are developmental
and exploratory, consistent with the grant mechanism that
supports the work (i.e., NIH Clinical Trial Planning Grant
Program, R34).
With regard to implementation feasibility (Aim 2), we
hypothesize that programs that report a greater number
of facilitators than barriers to CQI implementation will
achieve higher levels of CQI implementation; that higher
ratings on perceptions of key elements of diffusion of in-
novations (i.e., relative advantage, compatibility with
current work practices, ease of use, and observability of
benefits [31]) will lead to greater CQI implementation;
that organizational readiness to change will correlate
with higher levels of CQI implementation; and that pro-
grams that engage in a greater number of CQI activities
will experience higher overall levels of CQI implementa-
tion. In our evaluation of sustainment we expect that
programs that show higher levels of CQI activity during
the intervention will sustain more components than pro-
grams with lower levels of activity and that more posi-
tive perceptions of CQI and organizational readiness to
change at the end of the intervention will predict CQI
sustainment.
The RAND CQI intervention
The CQI intervention was designed to assist program staff
in utilizing the Plan-Do-Study-Act (PDSA) approach. The
PDSA approach was first developed by Walter Shewhart,
later refined by W. Edwards Deming [40], and recently
made popular in medical service settings by the Institute
Hunter et al. Addiction Science & Clinical Practice 2014, 9:4 Page 4 of 11
http://www.ascpjournal.org/content/9/1/4for Healthcare Improvement (IHI). We also utilized mate-
rials from RAND’s work in improving practice guideline
implementation in the U.S. Army’s medical systems [41]
and RAND’s collaborative quality improvement projects
with Phoenix House, a national addiction treatment
organization (R01 DA14969, Wenzel, PI) to help inform
development of the intervention. To adapt the previous
CQI approaches for community-based care, where out-
puts are services delivered rather than a tangible manufac-
tured product or a specific procedure (like hospital-based
care), changes in the terminology and measures were
made. We developed and piloted this CQI intervention in
conjunction with staff from a different SUD prevention
and treatment organization [8].
PDSA is an approach in which improvement strategies
are identified and tested using a small pre-post pilot
study approach. Results from small, pre-post pilots are
used to determine whether the change should be incor-
porated into a program’s standard practices. In the
RAND CQI intervention, CQI activities are framed
around regularly scheduled meetings during which staff
develop “CQI Actions” or specific improvement plans.
These plans are based on a systematic assessment of
program processes and on outcome data. The interven-
tion also incorporates an empowerment evaluation ap-
proach [42], where staff, with assistance from the PIs
and organizational leadership, systematically assess their
own programs and develop CQI Actions. Staff are coa-
ched on utilizing existing process and outcome data to
identify areas for improvement which are then vetted
within the larger organization. Process and outcome data
refer to information related to the admission and intake
process (e.g., waiting list and admission procedures), ser-
vice delivery (e.g., length of stay, type of treatment re-
ceived), and treatment impact (e.g., client discharge
status, client functioning after treatment ends). Follow-
ing the identification and vetting of a CQI Action, staff
implement the CQI Action, examine its impact, and de-
cide on next steps. During this period, programs re-
ceived technical assistance to help guide them through
the PDSA cycle. Program leaders are expected to meet
monthly throughout the process to discuss progress with
other participating program staff.
Implementation approach
We used the Simpson Transfer Model (STM) [43] as a
guide to plan implementation of the RAND CQI inter-
vention. The STM involves four stages of innovation
transfer: (1) Exposure, or introduction and training in
the innovation; (2) Adoption, which refers to an intention
to try the innovation through program leadership deci-
sions and subsequent support; (3) Implementation, or ex-
ploratory use of the innovation, with customization by the
organization; and (4) Practice, which refers to the routineuse of and performance feedback on the innovation. The
STM incorporates staff readiness to change [44] and Rog-
ers’ Diffusion of Innovation theory [31] at both the indi-
vidual (staff) and organizational levels. For example,
crucial to moving from the exposure to implementation
stage are resources provided by the institution (e.g., train-
ing, leadership), organizational characteristics such as “cli-
mate for change” (e.g., staff cohesion, presence of opinion
leaders, openness to change), and staff perceptions of the
innovations (e.g., complexity, benefit, and observability).
Consistent with this idea, the organizational change litera-
ture suggests that several factors are needed to put a new
business practice into place such as support and leader-
ship commitment [24], stakeholder involvement [25], re-
sources including money and materials, and access to
expertise [26]. More recently, an emerging literature re-
garding the diffusion of evidence-based treatment suggests
that training in a new intervention must be supported by
ongoing supervision or technical assistance in order for
new behaviors to be adopted and sustained [28,29].
The implementation of the RAND CQI intervention
incorporated these four stages of STM. Regarding Stages
1 and 2: Exposure and Adoption, the STM predicts that
adoption and exposure of a new innovation or interven-
tion are most likely to occur when facilitated by
organizational units that control resources and policies.
Therefore, we began the exposure and adoption stages
at the proposal phase by obtaining buy-in from the
Quality Assurance Director (Levan) and the Chief Ex-
ecutive Officer and Chief Operating Officer to ensure
that the organization provided support for training in
the intervention to clinical staff. Although a key element
of CQI is not intended to be a top-down approach, gain-
ing the support of key leadership is consistent with im-
plementation theories put forth by Aarons et al. [19] and
Fixsen et al. [26] that argue that leadership support is
critical for successful implementation. Upon receipt of
funding, the co-Principal Investigators (Hunter and
Levan) started to plan the intervention’s launch in a way
that would increase exposure across the organization
and start the implementation phase. Following baseline
data collection and randomization, the RAND CQI
intervention begins with regularly scheduled monthly
meetings to introduce key program staff (i.e., program
and/or clinical director and one member of the clinical
staff assigned to the intervention) to the PDSA cycle.
The organization is being compensated for staff partici-
pation in these meetings and the meetings are scheduled
at a time when staff did not have existing commitments
to enhance exposure.
The Stage 3 Implementation phase is characterized by
exploratory use of the intervention, supported by tools
and assistance. The monthly CQI meetings incorporate
active learning strategies that help promote retention
Hunter et al. Addiction Science & Clinical Practice 2014, 9:4 Page 5 of 11
http://www.ascpjournal.org/content/9/1/4and understanding of key concepts [45,46]. The meet-
ings are also designed to facilitate buy-in and account-
ability across the organization. The first three monthly
CQI meetings provide guidance to program staff on the
“Plan” phase of PDSA. More specifically, program staff
are asked to assess different parts of their program in-
cluding referral, intake, service delivery, and outcomes
to identify strengths and weaknesses that may be tar-
geted for improvement. During this process, staff are
also asked to link process and outcome goals to measur-
able objectives, which are documented in worksheets in-
cluded in the CQI toolkit. Following this data review
and planning process, staff are asked to identify and
document a “CQI Action” (i.e., a small improvement
plan) and document methods to study its impact (i.e.,
the “Do” and “Study” phases of PDSA). Accompanying
worksheets in the CQI toolkit are completed to docu-
ment the CQI Action, along with specific tasks and
timelines associated with it. This work occurs in a group
setting with assistance from the PIs and followed by
feedback by senior organizational leadership. Next, key
program staff continue to meet monthly to give updates
and discuss any challenges with the PDSA approach or
implementing their CQI Action. With the presence of
the organizational leadership at these meetings, problem-
solving that is contingent upon agency resources or
other leadership decisions are addressed. Following the
completion of the PDSA cycle, staff are guided by the
co-PIs to refine the first CQI Action or develop a new
CQI Action.
In Stage 4 Practice, performance monitoring and feed-
back, which are critical to implementing innovations,
are emphasized. The monthly meetings and contact via
email and phone between the participating staff and the
Implementation Team Leads (co-PIs, Hunter and Levan)
are designed to provide the coaching and feedback
needed to build and sustain competency [47]. Through-
out the practice phase, staff are asked to complete CQI
toolkit worksheets and share them with the Implementa-
tion Team Leads to assist in monitoring progress and
provide opportunities for feedback.
Measures and procedures
Process and outcome measures
To measure differences in process and outcome im-
provements between the intervention (Cohort 1) and
control (Cohort 2) groups, we are examining: (1) staff
job morale, (2) job satisfaction, (3) attitudes toward
adopting evidence-based practices, and (4) attrition. Cli-
ent outcomes are (1) length of stay in treatment, (2) sat-
isfaction with treatment, (3) clinical status at discharge,
and (4) post-treatment functioning.
To collect staff data, we are administering a web-based
survey to staff at six month intervals, starting with abaseline survey that is being administered prior to study
assignment. We are using the following measures to ob-
tain data on staff outcomes: Morale. The job morale
questionnaire consists of nine statements taken from the
emotional expression subscale of the Maslach Burnout
Inventory [48]. The inventory assesses feelings of emo-
tionally overextension and work exhaustion and has high
reliability (α = .90). Job Satisfaction. The job satisfaction
scale consists of six items related to satisfaction with dif-
ferent job aspects [49]. The scale is part of Texas Chris-
tian University’s Survey of Organizational Functioning
(TCU SOF) instrument [49] which measures 4 domains:
motivation for change, institutional resources, staff at-
tributes, and organizational climate. Evidence-Based Practice
Attitudes. To measure attitudes towards evidence-based
practices, we are using the Evidence-Based Practice At-
titude Scale (EBPAS) [50], a 15-item survey that assesses
providers’ attitudes about adopting EBPs; reported reli-
ability among mental health providers is good (α = .79).
Staff Attrition. We are monitoring staff employment rates
at each of the programs to track attrition rates throughout
the study. The participating organization keeps adminis-
trative records on employment.
Our measures of client outcomes are as follows:
Length of Stay. Client length of stay refers to the time
from treatment admission to the date of last service.
The organization maintains these data on all clients. Sat-
isfaction. The client satisfaction survey contains seven
yes/no survey items, as follows: (1) Was it easy to make
an appointment for assessment or admission; (2) Is the
staff polite and professional when you call on the phone;
(3) Are you treated with dignity and respect; (4) Is the
staff sensitive to you and your culture; (5) Are the
groups informative to you; (6) Did the staff ask you
about your strengths, needs, abilities, and preferences;
and (7) Did you take part in your treatment planning. In
addition, clients “grade” 4 aspects of their treatment on
a five-point scale (Very good; Good, Average, Poor, Very
Poor): the admission experience, counselor, facility/
accommodations, and treatment experience. Clinical Sta-
tus at Discharge. Participants are coded by their primary
treatment counselor as discharged with either positive or
negative compliance. Positive compliance is coded as:
completed treatment-referred/transferred, completed
treatment-not referred/transferred, left before completion
with satisfactory progress-referred/transferred, and left be-
fore completion with satisfactory progress-not referred/
transferred. Negative compliance is coded as: left before
completion with unsatisfactory progress–referred/trans-
ferred, left before completion with unsatisfactory progress–
not referred/transferred. Client Functioning Post-Treatment
is measured through a self-report survey that asks about the
past 60 days: frequency of substance use (response op-
tions: daily, 3-6 times/week, 1-2 times/week, 1-3 times/
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whether client (yes/no): a) has been arrested, b) is
employed or in school or job training, c) has received
emergency medical care, or d) is attending self-help
groups. All client outcome data rely on existing proce-
dures that the participating organization utilizes to
monitor its programs. This choice was primarily based
on the decision to build an intervention that could be
sustainable without the support of a research trial.
The organization tracks client length of stay in an ad-
ministrative database. Client satisfaction data are collected
at all programs during a quarterly “Client Satisfaction
Week” in which the organization’s Director of Quality As-
surance directs program directors to collect satisfaction
surveys on all clients in attendance during that week. Dis-
charge status is entered into the organization’s internal
database when clients exit the program (i.e., after comple-
tion of the program, transfer to another program, when
they leave a residential program, or 30 days without the
receipt of services in outpatient programs). Client func-
tioning post-treatment is assessed at 60 and 180 days fol-
lowing discharge. Clinical and non-clinical staff from the
programs phone clients to complete the survey at that
time by phone.Implementation feasibility measures
To measure feasibility, we are examining the processes
and extent of implementation, implementation costs,
and sustainment. We collect process and extent data in
three ways: (1) through semiannual semi-structured in-
terviews with program staff who have been involved in
the CQI meetings (i.e., program supervisors and clini-
cians); and (2) through surveys with the entire adminis-
trative and clinical staff that measure perceptions of CQI
and organizational functioning, including readiness to
change.
In the semi-structured interviews with key program
staff, we are collecting information on the extent and na-
ture of implementation of the PDSA cycle and on facili-
tators and barriers to implementation. We examine the
extent of PDSA activity using both open- and close-
ended interview questions based on an interview proto-
col developed to measure innovation use (Levels of
Innovation Use (LOU) interview by Hall & Hord [51]).
We are examining the nature of the CQI Actions
through open-ended questions, and progress within the
PDSA cycle through close-ended questions. To deter-
mine whether programs implement the Plan-Do-Study-
Act phases, we are coding how many of the stages of the
PDSA cycle (0-4) and how many PDSA cycles staff
achieved during the intervention period. To examine fa-
cilitators and barriers to implementation, we are using
items adapted from Scheier et al. [52] and Grol andWensing’s [53] standard items for evaluating barriers
and facilitators.
Through web-based staff surveys conducted every six
months, we are evaluating perceptions of CQI and
organizational readiness to change. To measure percep-
tions of CQI, we adapted Moore and Benbasat’s [54] in-
strument that measures Roger’s elements of diffusion.
Sub-scales of this instrument include relative advantage
over usual practices (5 items; α = 0.90), the complexity/
ease of use (4 items; α = 0.84), compatibility (3 items; α =
0.86), observability/demonstrability (4 items; α = 0.79),
and trialability of the innovation (2 items; α = 0.71). To
measure organizational readiness to change we are using
Texas Christian University’s Survey of Organizational
Functioning (TCU SOF) instrument [49] which measures
4 domains: motivation for change, institutional resources,
staff attributes, and organizational climate.
CQI Costs We are capturing the direct and indirect
costs of CQI activities using modified versions of the
standardized cost instrument for drug treatment ser-
vices, the Substance Abuse Services Cost Analysis Pro-
gram (SASCAP™) Labor and Cost Modules. As an
innovation in costing SUD treatment programs, we also
are attempting to capture opportunity costs, that is, the
activities forfeited to conduct CQI activities. Specifically,
our costing strategy captures the following: Direct cost –
the direct expense outlay to accomplish given CQI activ-
ities; Indirect cost – the amount of time, effort and other
organizational resources spent, but not as a direct cash
outlay, for CQI activities; and the Opportunity cost –
the net benefit of the activities foregone. The costing ap-
proach is based on the principle of Activity-Based Cost-
ing (ABC), using the data collection tools and interviews
with staff members to define staff activities involved in
the additional CQI intervention activities, and asking
staff how they allocate their time to these activities and
then in turn to products and services.
We modified the SASCAP Labor- and Cost-Modules
for non-methadone outpatient services [55,56] to in-
clude aspects of residential services for those sites. Fur-
thermore, unlike the focus of SASCAP, which is on the
overall cost of one treatment program, the CQI project
involves a large range of activities of varying time
expended. As such, we are implementing a monthly cost
questionnaire to more accurately attribute time spent on
CQI activities and materials purchased rather than rely-
ing on reports at less frequent intervals.
The annual cost data collection tool includes the fol-
lowing: General information about the clients served in-
cluding census, capacity, and length of stay; information
about average salaries and number of employees, by cat-
egory of personnel; capital expenses for the program, or-
ganized by category – including equipment, materials
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operational expenses used for client care, organized by
category – including equipment, office supplies and util-
ities. Given the data systems in place and the need to re-
duce reporting burden, we designed a ‘corporate’ and
‘program’ version, each with unique questions. Facility
program directors and a corporate compliance officer
meet with a cost study analyst to input data for each
cost line item using administrative, financial data. The
annual cost questionnaire is filled out for the year prior
to CQI (baseline) and during the year of CQI, allowing
for analysis as to whether CQI affected other costs
indirectly.
The monthly questionnaire collects: a) Information
about man-hours spent by category of personnel and
CQI activity; and b) Recurrent operational expenses used
for CQI activities specifically, organized by category –
including equipment, office supplies, and utilities. In the
CQI trial, program staff are advised to keep in mind the
CQI activities that they and other staff at their site per-
form. During each monthly CQI meeting, program staff
recall those activities and fill out the questionnaire re-
garding time spent and materials purchased over the last
month as a direct result of engaging in CQI.
Sustainment To assess whether CQI activities are sus-
tained, we plan to examine data collected from Cohort 1
during the Phase 1 implementation interviews and again
during the Phase 2 period when the Cohort 1 programs
are no longer receiving the intervention. These data will
inform us about which CQI activities are sustained in
Cohort 1 (if any), and about facilitators and barriers to
sustainment. To collect these data, we are building upon
the semi-annual implementation interview protocol in
two ways. First, during the last set of Cohort 1 inter-
views, we are asking program staff about their plans to
sustain CQI. Second, during the Cohort 2 intervention
period, we are asking Cohort 1 staff whether the differ-
ent components of the intervention are continuing, that
is, whether regular CQI meetings are taking place.
Analytic methods
The randomization of programs to study conditions is
necessary given the CQI intervention is intended to
change program-level practices. However, it is important
to assess the effect of the multilevel study design on the
statistical power to detect intervention effects [57]. One
key component of the power calculations is the intra-
cluster correlation (ICC), which is the proportion of the
overall variance in the outcomes that is attributable to
program membership. For a given sample size, statistical
power decreases as ICC increases. We therefore present
below our analytic approach for the analysis of each out-
come, and note for which outcomes we expect to havesufficient statistical power to examine, based on ICC
data from previous studies.Intervention efficacy
The first set of analyses will focus on examining the ef-
fect of the CQI intervention on staff outcomes relative
to the control condition (Aim 1). The hypotheses related
to staff outcomes are that staff participating in the CQI
intervention will demonstrate improvements in: a) job
morale, b) job satisfaction, and c) attitudes towards EBPs
as compared with staff assigned to the control condition.
Improvement will be measured as the difference be-
tween pre-intervention and post-intervention (i.e., end
of Phase 1) assessments. Improvement in staff-level out-
comes will be modeled using linear multilevel regression
modeling, controlling for baseline values of job morale
(a), job satisfaction (b), and attitudes towards EBPs (c)
when modeling those outcomes. The multilevel model
structure will account for the similarity, or intra-cluster
correlation (ICC), among staff outcomes within the pro-
gram. The statistical significance of a dichotomous pre-
dictor of participating in the CQI intervention and its
direction will be examined to test these hypotheses. We
will also examine whether programs that participate in
the CQI intervention experience lower staff attrition
than programs assigned to the control condition (d).
Given the sample size of programs in the study, we will
use descriptive statistics to examine whether staff attrition
is lower for staff participating in the CQI intervention.
For analyses of the staff-level outcomes (a-c), we as-
sume an intra-cluster correlation (ICC) of 0.040 for
staff-level outcomes, which is obtained by averaging
ICCs for data on similar measures from two external
studies. One ICC estimate is from staff attitudes toward
implementing ‘Getting To Outcomes,’ a site-level inter-
vention that incorporates CQI and other elements to in-
crease organizational evaluation capacity [58]. Other
ICC estimates are for subscales from the Organizational
Readiness for Change (ORC) instrument [49] that was
implemented at four SUD treatment program sites from
same organization participating in a prior RAND study
[59]. We will have 80% power (alpha = 0.05, two-sided
test) to detect an effect size of 0.63 standard deviations
(SDs). Our analyses of staff attrition (d) will be limited
to exploratory analyses given the lack of statistical power
for formally testing whether CQI has an effect on
attrition.
The second set of analyses will focus on client out-
comes. As most client-level outcomes are reported di-
chotomously, we will fit for most outcomes multilevel
binomial regression models to test these hypotheses.
Other forms of the generalized multilevel model will be
used for continuous outcomes as appropriate. The
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ing assigned to the CQI intervention will be examined.
Table 1 summarizes the power calculations for the
client-level outcomes. Column 1 provides an estimate of
the intra-class correlation (ICC) from the preliminary
program data; column 2 shows the base rate assumed
for the comparison group on each outcome available to
us in preliminary program data; and column 3 shows the
percentage point difference in the outcome between the
intervention versus control arm (assuming it maintained
the assumed base rate) that would be detectable with
80% power (alpha = 0.05, two-sided test). The arrest rate
outcome is not presented in this table, as its base rate is
too low and ICC too high to yield an outcome for which
we would have sufficient statistical power to detect
meaningful effects.
Feasibility
To examine the process and extent of CQI implementa-
tion, we will examine whether higher ratings of relative
advantage, compatibility, observability and trialability,
and organization readiness to change will be correlated
with higher levels of CQI implementation. CQI imple-
mentation will be assessed by ratings of PDSA Activity.
Ratings of innovation attributes and organizational cli-
mate will be associated with PDSA Activity. We will test
this hypothesis by regressing each staff-level outcome
(relative advantage, compatibility, observability and
trialability, and organization readiness to change) on
PDSA Activity rating at follow-up, while controlling
for baseline values of these measures. The statistical
significance and direction of the coefficient on the
PDSA Activity will be examined to test this hypothesis.
Under similar assumptions about the ICC of responses
among staff within programs, we will have 80% power
(alpha = 0.05) to detect whether PDSA Activity rating
predicts at least 17% of the variance (e.g., R2 = 0.17) ofTable 1 Percentage point difference detectable assuming con
Outcomes (1) Intra-clu
Length of stay > 90 days 0.008
Satisfaction:% rating treatment experience as ‘Very Good’ 0.110
% giving counselor a 'Very good’ rating 0.038
Positive compliance 0.002
% weekly or more frequent substance use* 0.048
Employed or in school* 0.150
Positive employment activities* 0.010
Emergency medical care* 0.009
Attended self-help groups* 0.008
*Measured at baseline and follow-up. The power calculations reflect the assumption
measure is 0.7 and that the baseline measure is a covariate in the analytic model.each outcome. To examine whether programs that en-
gage in a greater number of CQI activities will experi-
ence higher levels of CQI implementation, we will
assess the number of CQI activities (workshop and
CQI meeting attendance, worksheet completion) by
each program to assess the extent of CQI activity. CQI
implementation will be assessed by ratings of PDSA
Activity. We will test this hypothesis by examining the
correlation between the number of CQI activities com-
pleted and PDSA Activity.
Sustainment
To examine whether perceptions of CQI and organizational
readiness to change at the end of the intervention will pre-
dict CQI sustainment, we will explore bivariate relation-
ships between innovation attributes (i.e., perceptions of
the CQI’s relative advantage, complexity, observability,
and trialability) and organizational climate as assessed at
the end of the intervention with sustainment at end of
Phase 2, examining the correlation between the two. We
will have 80% power (alpha = 0.05) to detect whether
PDSA Activity rating predicts at least 31% of the variance
(e.g., R2 = 0.31) of each outcome; given the power limita-
tions this should be regarded as a descriptive rather than
inferential analysis.
Costs
Since the monthly cost surveys are activity-based and
the interview questions on costs will provide details for
how time on CQI activities were spent (e.g., additional
work, part of work already doing), we will initially de-
scribe direct costs associated with key types of CQI
activities. We will then aggregate these activities and use
findings from the annual cost survey and interviews to
provide a description of the direct and indirect costs
of implementing CQI. Given the lack of information re-
garding CQI costs, we view this in itself as a contributiontrol group base rate and intra-cluster correlations













that the correlation between baseline and follow-up observations of the same
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duct a standard cost analysis comparing costs between the
facilities that receive the intervention and facilities that
had not yet, according to the cohort schedule.
Discussion
The present study offers a much-needed, innovative strat-
egy for implementing CQI in SUD treatment settings.
While CQI may offer ways to improve SUD treatment, we
cannot assume that it can be easily transported into prac-
tice or that it will have the same impact as it has had in
more traditional healthcare settings [60]. Organizations do
not always adopt new practices even when they are known
to improve outcomes [61]. Further, attention needs to be
paid to factors both at the individual and organizational
levels that impact the degree to which new practices are
adopted and implemented. For example, a number of
studies have shown that factors at both the individual level
(e.g., training, skills, efficacy, involvement in decision mak-
ing, and job satisfaction) and at the organizational level
(organization size, climate, and financial resources, and ac-
tive leadership support) predict successful program imple-
mentation [61-66].
Our strategy for bringing CQI into SUD treatment set-
tings addresses many of these needs and potential trans-
portability barriers. First, collaboration with organizational
leadership and their active participation in meetings and
workshops helps tailor the intervention to the needs of
the organization and lends credibility to the intervention.
Next, the study provides clinical staff with skills to make
small improvements to enhance treatment quality and in-
volves them in decision-making and planning activities.
And finally, through hands-on skill-building meetings and
ongoing technical assistance, the intervention offers an ac-
tive learning environment for staff at multiple levels.
Moreover, the study offers a unique design that provides
a way to maximize the collection of feasibility, costs, effi-
cacy, and sustainment of the intervention in a pilot study.
In particular, data collection instruments were designed to
permit a relatively comprehensive analysis of the interven-
tion, yet were implemented so as to reduce the burdens of
data collection and performance of multiple analyses. Al-
though we are somewhat limited by testing the intervention
in a single organization, it is recommended that early stage
intervention studies take place in a single organization to
eliminate the potential loss of power involved in statistically
adjusting for organizational differences [67]. Another po-
tential limitation of the study is that the proposed assess-
ments (i.e., staff and client outcomes) may not adequately
reflect change as the result of a type of CQI interventions
selected. That is, because program staff determine the
CQI improvement strategy and it is likely to differ across
programs, it is not known how well a specific intervention
will be aligned with the outcomes being evaluated in thestudy. To address this limitation, the study captures both
staff and client level changes, as CQI strategy may influ-
ence one but not the other. This is also consistent with
the results from CQI practiced in traditional health care
settings, where studies have shown that CQI efforts have
demonstrated tangible results to both patients and pro-
viders [68]. In summary, we hope that this study design
offers a template for those wishing to efficiently study
intervention feasibility, cost, efficacy, and sustainment in a
pilot study which may shorten the time between interven-
tion development and translation into real world practice
settings.
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